Dudediligence.

bioAffinity Technologies, Inc

BIAFNASDAQ · Services-Commercial Physical & Biological Research
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.4MSep ’24$2.2MDec ’24$1.9MMar ’25$1.3MJun ’25$1.4MSep ’25$1.6MDec ’25$1.4MMar ’26$1.5MJun ’26
Net income, by quarter
−$2.0MSep ’24−$3.0MDec ’24−$2.7MMar ’25−$4.1MJun ’25−$5.1MSep ’25−$3.1MDec ’25−$3.6MMar ’26−$3.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$4,803$2.5M$9.4M$6.2M
Gross profitnone on file$4,336none on filenone on filenone on file
Operating income−$2.2M−$4.0M−$8.0M−$9.0M−$10.6M
Net income−$6.3M−$8.2M−$7.9M−$9.0M−$14.9M
Operating cash flow−$2.0M−$4.1M−$6.0M−$7.3M−$9.3M
Free cash flownone on file−$4.3M−$6.1M−$7.3M−$9.4M
Cash$1.4M$11.4M$2.8M$1.1M$6.4M
Shares outstanding2.7M8.4M9.4M519.2K4.5M